UTS2B (urotensin 2-related peptide) is a member of the urotensin peptide family, structurally related to urotensin II (UTS2). Encoded by the *UTS2B* gene, it binds to the G-protein-coupled receptor GPR14 (UT receptor), sharing partial homology with UTS2 but exhibiting distinct tissue expression and biological roles. UTS2B is primarily expressed in the central nervous system, cardiovascular tissues, and kidneys, where it modulates vascular tone, inflammation, and cellular proliferation. Its dual role as both a vasoconstrictor and vasodilator, depending on tissue context, has sparked interest in its involvement in hypertension, heart failure, and metabolic disorders.
Antibodies targeting UTS2B are critical tools for elucidating its physiological and pathological functions. They enable precise detection and localization of UTS2B in tissue samples (e.g., via immunohistochemistry) and quantification in biological fluids (e.g., ELISA). Such antibodies have facilitated studies linking UTS2B dysregulation to conditions like atherosclerosis, diabetes, and renal fibrosis. Recent research also explores its potential as a biomarker or therapeutic target. However, challenges remain in ensuring antibody specificity due to structural similarities between UTS2B and other urotensin family members. Validated antibodies are essential for advancing translational research, particularly in understanding UTS2B’s role in cross-talk between metabolic and cardiovascular systems.